ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,913Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 1442

$663K Total Retail Price of All Prescriptions

Rank: 61 out of 1442

497 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 7,696 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 535 510 1 3
METOPROLOL SUCCINATE 366 356 2 1
SIMVASTATIN 267 265 3 2
PRAVASTATIN SODIUM 253 250 4 20
ZOLPIDEM TARTRATE 244 244 5 25
ATORVASTATIN CALCIUM 233 229 6 4
LEVOTHYROXINE SODIUM 194 179 7 22
CRESTOR 187 180 8 10
RAMIPRIL 184 164 9 18
SYNTHROID 146 145 10 40
LIPITOR 144 144 11 24
FUROSEMIDE 143 139 12 5
TRICOR 143 125 12 100
DIGOXIN 132 128 14 15
NEXIUM 127 127 15 34
LOSARTAN POTASSIUM 125 125 16 13
METFORMIN HCL 123 121 17 26
WARFARIN SODIUM 121 121 18 9
BENICAR 104 100 19 61
LOVAZA 97 97 20 37
HYDROCHLOROTHIAZIDE 95 95 21 16
DIOVAN 92 83 22 19
OMEPRAZOLE 88 88 23 21
ALLOPURINOL 86 86 24 47
AZITHROMYCIN 81 78 25 56
BYSTOLIC 76 69 26 32
CHLORTHALIDONE 74 70 27 68
CARVEDILOL 71 68 28 8
SPIRONOLACTONE 69 66 29 28
METOPROLOL TARTRATE 66 66 30 6
NIASPAN 60 60 31 57
DOXAZOSIN MESYLATE 58 58 32 69
TRAMADOL HCL 56 56 33 97
BENICAR HCT 56 56 33 86
GABAPENTIN 53 53 35 55
TOPROL XL 52 52 36 51
ESCITALOPRAM OXALATE 50 46 37 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.